Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$7.71 - $11.56 $20.9 Million - $31.3 Million
-2,709,286 Reduced 59.65%
1,832,740 $21.2 Million
Q3 2023

Nov 13, 2023

SELL
$8.91 - $10.91 $375,191 - $459,409
-42,109 Reduced 0.92%
4,542,026 $41.5 Million
Q2 2023

Aug 11, 2023

SELL
$7.14 - $9.29 $273,026 - $355,240
-38,239 Reduced 0.83%
4,584,135 $42 Million
Q1 2023

May 11, 2023

SELL
$6.65 - $10.69 $99,823 - $160,467
-15,011 Reduced 0.32%
4,622,374 $34.1 Million
Q4 2022

Feb 13, 2023

SELL
$5.96 - $8.53 $13.6 Million - $19.4 Million
-2,279,208 Reduced 32.95%
4,637,385 $39.4 Million
Q3 2022

Nov 10, 2022

SELL
$5.95 - $14.3 $6.46 Million - $15.5 Million
-1,085,096 Reduced 13.56%
6,916,593 $42.6 Million
Q2 2022

Aug 12, 2022

SELL
$10.6 - $13.28 $8.36 Million - $10.5 Million
-788,643 Reduced 8.97%
8,001,689 $95.1 Million
Q1 2022

May 13, 2022

SELL
$10.37 - $12.73 $508,741 - $624,521
-49,059 Reduced 0.56%
8,790,332 $103 Million
Q4 2021

Feb 14, 2022

BUY
$10.21 - $15.27 $73,358 - $109,714
7,185 Added 0.08%
8,839,391 $99.3 Million
Q3 2021

Nov 15, 2021

BUY
$14.07 - $17.3 $8.46 Million - $10.4 Million
601,172 Added 7.3%
8,832,206 $129 Million
Q2 2021

Aug 13, 2021

SELL
$16.62 - $18.94 $1.22 Million - $1.39 Million
-73,651 Reduced 0.89%
8,231,034 $143 Million
Q1 2021

May 14, 2021

SELL
$15.15 - $19.78 $13.7 Million - $17.8 Million
-901,145 Reduced 9.79%
8,304,685 $144 Million
Q4 2020

Feb 08, 2021

BUY
$16.86 - $19.67 $753,945 - $879,603
44,718 Added 0.49%
9,205,830 $170 Million
Q3 2020

Nov 13, 2020

SELL
$15.4 - $20.16 $40.8 Million - $53.4 Million
-2,648,108 Reduced 22.42%
9,161,112 $159 Million
Q2 2020

Aug 13, 2020

SELL
$18.24 - $21.45 $8.78 Million - $10.3 Million
-481,323 Reduced 3.92%
11,809,220 $215 Million
Q1 2020

May 14, 2020

BUY
$16.28 - $25.63 $535,221 - $842,611
32,876 Added 0.27%
12,290,543 $248 Million
Q4 2019

Feb 07, 2020

BUY
$19.57 - $23.52 $8.71 Million - $10.5 Million
444,860 Added 3.77%
12,257,667 $285 Million
Q3 2019

Nov 13, 2019

BUY
$19.85 - $22.76 $41.5 Million - $47.6 Million
2,089,584 Added 21.49%
11,812,807 $237 Million
Q2 2019

Aug 13, 2019

BUY
$17.59 - $21.1 $27.3 Million - $32.8 Million
1,552,281 Added 19.0%
9,723,223 $205 Million
Q1 2019

May 13, 2019

BUY
$18.01 - $20.11 $16 Million - $17.8 Million
887,474 Added 12.18%
8,170,942 $164 Million
Q4 2018

Feb 13, 2019

BUY
$17.44 - $21.53 $55.9 Million - $69 Million
3,204,013 Added 78.54%
7,283,468 $134 Million
Q3 2018

Nov 09, 2018

SELL
$19.97 - $21.96 $25.7 Million - $28.3 Million
-1,288,199 Reduced 24.0%
4,079,455 $87.2 Million
Q2 2018

Aug 10, 2018

SELL
$20.16 - $24.68 $4.33 Million - $5.3 Million
-214,599 Reduced 3.84%
5,367,654 $115 Million
Q1 2018

May 14, 2018

BUY
$20.31 - $24.95 $24.6 Million - $30.2 Million
1,209,240 Added 27.65%
5,582,253 $118 Million
Q4 2017

Feb 12, 2018

SELL
$20.99 - $23.89 $5.06 Million - $5.76 Million
-241,119 Reduced 5.23%
4,373,013 $100 Million
Q3 2017

Nov 13, 2017

BUY
$20.07 - $21.89 $25.5 Million - $27.9 Million
1,272,464 Added 38.08%
4,614,132 $101 Million
Q2 2017

Aug 29, 2017

BUY
N/A
3,341,668
3,341,668 $70.6 Million

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $5.31B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Fil LTD Portfolio

Follow Fil LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fil LTD, based on Form 13F filings with the SEC.

News

Stay updated on Fil LTD with notifications on news.